APA (7th ed.) Citation

NP, S., S, J., B, R., SR, P., GJ, K., KM, S., . . . VGM, N. (2023). AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma. JHEP reports : innovation in hepatology, 6(2), 100974. https://doi.org/10.1016/j.jhepr.2023.100974

Chicago Style (17th ed.) Citation

NP, Syamprasad, et al. "AKR1B1 Drives Hyperglycemia-induced Metabolic Reprogramming in MASLD-associated Hepatocellular Carcinoma." JHEP Reports : Innovation in Hepatology 6, no. 2 (2023): 100974. https://doi.org/10.1016/j.jhepr.2023.100974.

MLA (9th ed.) Citation

NP, Syamprasad, et al. "AKR1B1 Drives Hyperglycemia-induced Metabolic Reprogramming in MASLD-associated Hepatocellular Carcinoma." JHEP Reports : Innovation in Hepatology, vol. 6, no. 2, 2023, p. 100974, https://doi.org/10.1016/j.jhepr.2023.100974.